Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [360]
News [1775]
Articles [88]
Editorials [3]
Conferences [74]
elearning [15]

Highlights from IGILUC 2019

Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt
Highlights from IGILUC 2019 ( Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt )
8 May 2019

PARP inhibitors and their side effects in solid tumour therapy

Paula Anastasia - David Geffen School of Medicine at UCLA Los Angeles, USA
PARP inhibitors and their side effects in solid tumour therapy ( Paula Anastasia - David Geffen School of Medicine at UCLA Los Angeles, USA )
8 May 2019

KEYNOTE 189: Targeting NSCLC patients with brain and liver metastases

Dr Marina Garassino - National Tumor Institute, Milan, Italy
KEYNOTE 189: Targeting NSCLC patients with brain and liver metastases ( Dr Marina Garassino - National Tumor Institute, Milan, Italy )
15 Apr 2019

Immune checkpoint inhibitor combination efficacious for patients with high-grade neuroendocrine carcinoma

Prof Sandip Patel - UC San Diego, San Diego, USA
Immune checkpoint inhibitor combination efficacious for patients with high-grade neuroendocrine carcinoma ( Prof Sandip Patel - UC San Diego, San Diego, USA )
11 Apr 2019

Sequencing Sorafenib and Regorafenib in advanced hepatocellular carcinoma – Brought to you by Oncology Knowledge into Practice

Prof Josep Llovet, Dr Richard Finn
Sequencing Sorafenib and Regorafenib in advanced hepatocellular carcinoma – Brought to you by Oncology Knowledge into Practice ( Prof Josep Llovet, Dr Richard Finn )
25 Feb 2019

Pan-cancer assessment of BRCA1/2 genomic alterations by comprehensive genomic profiling of tissue and circulating tumour DNA

Dr Neeraj Agarwal - Huntsman Cancer Institute, Salt Lake City, Utah
Pan-cancer assessment of BRCA1/2 genomic alterations by comprehensive genomic profiling of tissue and circulating tumour DNA ( Dr Neeraj Agarwal - Huntsman Cancer Institute, Salt Lake City, Utah )
25 Oct 2018

Two important pancreatic studies: PRODIGE 24 and PREOPANC

Dr Kenneth Yu - Memorial Sloan Kettering Cancer Center, New York, USA
Two important pancreatic studies: PRODIGE 24 and PREOPANC ( Dr Kenneth Yu - Memorial Sloan Kettering Cancer Center, New York, USA )
7 Aug 2018

MyPathway study: a novel precision oncology multiple basket trial

Dr Mary S. Beattie - Genentech, USA
MyPathway study: a novel precision oncology multiple basket trial ( Dr Mary S. Beattie - Genentech, USA )
6 Jul 2018

Editor's Choice for June 2018

Prof Gordon McVie - Founding Editor, ecancer
Editor's Choice for June 2018 ( Prof Gordon McVie - Founding Editor, ecancer )
4 Jul 2018

ASCO 2018 conference round up

Dr Bishal Gyawali and Will Davies
ASCO 2018 conference round up ( Dr Bishal Gyawali and Will Davies )
24 Jun 2018

Pancreatic survival improved with trial chemotherapy regimen after surgery

Dr Thierry Conroy - Institute Cancer De Lorraine, Nancy, France
Pancreatic survival improved with trial chemotherapy regimen after surgery ( Dr Thierry Conroy - Institute Cancer De Lorraine, Nancy, France )
4 Jun 2018

Comment: Pancreatic cancer survival extended by over a year with chemotherapy regimen

Dr Andrew Epstein and Prof Richard Schilsky
Comment: Pancreatic cancer survival extended by over a year with chemotherapy regimen ( Dr Andrew Epstein and Prof Richard Schilsky )
4 Jun 2018

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation